For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.
Price · 1Y
$402.81
Thesis
Dave is a small-cap US neobank challenger built around the ExtraCash short-dated cash advance product, with a checking account attached. Following a near-zero post-deSPAC drawdown, the company has executed an operational turnaround and returned to GAAP profitability on a small base.
The investment case is leverage to continued ExtraCash unit-economics improvement and disciplined customer-acquisition cost — at this scale, modest revenue beats compound to large EPS movements. Risks: regulatory scrutiny of cash-advance products, intense neobank competition for the same low-income demographic, and limited durable moat.
Catalysts
- ExtraCash transaction volume and credit performance
- Monthly active member growth
- Operating leverage at sub-$500M revenue scale
- Regulatory environment for tip-based cash advance products
Recent events
Material filings, federal awards, and regulatory activity. Impact is scored against market cap.